Helicon Proactivate securely analyses hospital and primary care data, to identify hard-to-reach “missing” patients and uses powerful machine learning algorithms 
to predict those at high risk of stroke in next 1 to 3 years (“likely”).

We work with commissioners and providers to design and implement targeted screening, prevention and care pathways to reduce stroke incidence and cost.

Helicon has a set of health economic models which we use with customers to explore the impact of different pathway options. Typical options include the targeted screening programme, the choice of anticoagulant and patient self-testing.